Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-BrEATHe - Interactions Between Antiretrovirals And Transgender Hormones
NCT04050371Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Aug 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by University of California, San Francisco. Started Aug 2017; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04050371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04050371.